By John R. Graham | Monday March 13, 2017 at 10:04 AM PDT | Comments Off on New Study Misdiagnoses Elevated U.S. Drug Prices
An interesting research article at the Health Affairs blog last week asserts there is no relationship between high U.S. prescription drug prices and drug companies’ research and development budgets. The point of the article is to debunk the argument that research-based drug companies must earn high profits if they are going to reinvest in...
Read More »
Tags: patents, pharmaceutical prices, R&D
By Lawrence J. McQuillan | Tuesday August 25, 2015 at 5:17 PM PDT | Comments Off on The Decline in R&D Efficiency in the Drug Industry
Panel “a” in the graphic below shows that the number of new drugs approved by the U.S. Food and Drug Administration (FDA) per billion U.S. dollars spent on research and development (R&D) in the drug industry has halved about every nine years since 1950, in inflation-adjusted terms. This represents a decline in drug R&D...
Read More »
Tags: drug industry, FDA, HIV, PDUFA, pharmaceuticals, R&D, research and development, thalidomide, U.S. Food and Drug Administration